IRON
Disc Medicine, Inc.
Biotechnology · Healthcare · United States
80.84
close · 2026-10-30
value
92
cheaper than peers92
quality
60
stronger fundamentals60
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 3 years ago | -1.2% | 91 |
| earnings yield, 2 years ago | -4.2% | 91 |
| cash flow yield, 2 years ago | -2.0% | 89 |
| earnings yield, 1 year ago | -4.9% | 84 |
| cash flow yield, 1 year ago | -2.6% | 83 |
| earnings yield, latest year | -7.4% | 82 |
| cash flow yield, latest year | -5.1% | 82 |
| earnings yield, 3 years ago | -55.7% | 50 |
| price to book | 4.81× | 31 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | -39.1% | 75 |
| operating margin | 0.0% | 50 |
| debt to equity | 9.4% | 41 |
3 of 4 measures available
Facts
| market cap | $4B |
| free cash flow | -$117.5M |
| employees | 165 |
| first trade | 2020-08-12 |
| next earnings | not reported |
| fundamentals updated | 2026-08-07 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | -6.01 | -3.96 | -3.42 | -45.05 | not reported |
| free cash flow | -$181.3M | -$94.4M | -$73.6M | -$42.4M | not reported |
| net income | -$212.2M | -$109.4M | -$76.4M | -$46.8M | not reported |
| revenue | $0 | $0 | $0 | $0 | not reported |
| unusual items | not reported | not reported | not reported | -$61,000 | -$5.0M |